Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$0.19 - $0.45 $4,049 - $9,590
21,313 Added 6.58%
344,992 $80,000
Q3 2021

Nov 12, 2021

BUY
$1.38 - $2.15 $9,931 - $15,473
7,197 Added 2.27%
323,679 $559,000
Q2 2021

Aug 13, 2021

BUY
$1.98 - $2.74 $119,160 - $164,898
60,182 Added 23.48%
316,482 $689,000
Q1 2021

May 12, 2021

BUY
$0.8 - $2.85 $153,897 - $548,260
192,372 Added 300.92%
256,300 $666,000
Q1 2020

May 14, 2020

BUY
$0.68 - $2.14 $716 - $2,253
1,053 Added 1.67%
63,928 $46,000
Q2 2019

Aug 14, 2019

BUY
$1.02 - $2.04 $12,006 - $24,012
11,771 Added 23.03%
62,875 $107,000
Q1 2019

May 14, 2019

BUY
$1.65 - $3.29 $5,517 - $11,001
3,344 Added 7.0%
51,104 $84,000
Q4 2018

Feb 13, 2019

BUY
$1.5 - $5.4 $71,640 - $257,904
47,760 New
47,760 $71,000

About ENDRA Life Sciences Inc.


  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $322M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.